Beyond Biotech - the podcast from Labiotech
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
Podcasting since 2022 • 159 episodes
Beyond Biotech - the podcast from Labiotech
Latest Episodes
Day One DNA: How and why the UK is betting on whole genome sequencing for every newborn
The UK is preparing to change the game for healthcare - but why, how, and what will it cost?Recently the UK government announced plans to sequence the DNA of every baby born in that country. A part of the country’s 10 Year Health ...
•
Episode 159
•
49:57
Meatly's innovative cultivated meat is already delighting pets, are humans next?
Is cultivated meat the future of pet food? And is there a place for cultivated meat on human dinner tables, too?Traditional agricultural methods are slow, require large tracts of land, significant energy and environmental inputs, ...
•
Episode 158
•
38:45
Cryoport Systems on the state of the ATMP market and the importance of supply chain resilience
With supply chain management and optimization, risk management, and the capacity to address global markets efficiently and effectively top of mind for all growing biotechs, I'm excited to be joined by Alison Pritchard, Vice President, Business ...
•
Episode 157
•
48:30
Taking the fight to inflammatory disease: InflaRx’s first-in-class C5a/C5aR signaling pathway strategy
Inflammatory diseases involve excessive or ongoing inflammation that damages tissues and affects many different human systems, including digestion, immunity, circulation, breathing, and the nervous system. The demand for anti-inflammatory treat...
•
Episode 156
•
39:24
How OMass Therapeutics is tackling congenital adrenal hyperplasia, a rare genetic disorder
Ros Deegan is an industry leader and the CEO of OMass Therapeutics, an Oxford-based biotechnology company discovering medicines against highly-validated target ecosystems, such as membrane proteins or intracellular complexes. OMass...
•
Episode 155
•
34:27